Concepedia

Author

Hasmukh Jain

Tata Memorial HospitalORCID

Also Known As

Dhanlaxmi Shetty, Dr. Hasmukh Jain, H Jain, H. Jain, H. K. Jain, Harsh Jain, Harshit jain, Hasmukh Jain, Himani Jain, Jain H

255

Publications

1.1K

Citations

17

H-Index

20

Concepts

All Affiliations

Tata Memorial HospitalHomi Bhabha National InstituteAdvanced Centre for Treatment, Research and Education in CancerIndian Institute of Technology BombayHCG Cancer Hospital
HJ

About

Hasmukh Jain is an author at Tata Memorial Hospital specializing in cancer research, humanities, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Humanities

2

2

28

2

Medicine

2

2

38

3

Health Sciences

1

1

15

4

Public Health

1

1

23

5

Epidemiology

1

1

23

Hasmukh Jain

×

27

Publications

620

Citations

15

H-Index

YearCitations

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh,

Leukemia

2021

92

Insights into the mechanism of natural terpenoids as NF-kB inhibitors: an overview on their anticancer potential

Hasmukh Jain, Naveen Dhingra, Tamanna Narsinghani,

Experimental Oncology

2016

43

Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

Prashant Tembhare, Harshini Sriram, Twinkle Khanka,

Journal for ImmunoTherapy of Cancer

2020

41

COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment

Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik,

Cancer Medicine

2020

39

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemia

Nikhil Patkar, Rohan Kodgule, Chinmayee Kakirde,

Oncotarget

2018

34

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells

Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh,

Molecular Cancer Therapeutics

2021

31

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol

Akhil Rajendra, Hasmukh Jain, V. N. Avinash Bonda,

Blood Advances

2021

30

The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients

Sushant Kumar, Bhavuk Dhamija, Soumitra Marathe,

Molecular Cancer Research

2020

28

Outcomes of COVID-19 and risk factors in patients with cancer

Manju Sengar, Girish Chinnaswamy, Priya Ranganathan,

Nature Cancer

2022

23

Induction Related Mortality in Acute Myeloid Leukemia: Multivariate Model of Predictive Score from the Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)

Smita Kayal, Manju Sengar, Hasmukh Jain,

Blood

2019

22

Page 1